在TNBC中表达四个癌症丸抗原,表明潜在的普遍免疫治疗点
Jie Xiao1, Fengli Huang2, Lin Li3
1Department of Oncology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China.
Journal of cancer research and clinical oncology
|August 23, 2023
概括
像MAGE-A4和PRAME这样的癌症丸抗原 (CTA) 在三阴性乳腺癌 (TNBC) 中高度表达. 它们的表达与更长的无病生存时间相关,这表明免疫治疗的潜力.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 遗传学 遗传学 是一个
背景情况:
- 免疫疗法为乳腺癌治疗提供了一个有希望的途径.
- 癌症丸抗原 (CTA) 在瘤中被选择性表达,使它们成为理想的免疫治疗点.
- 研究乳腺癌中CTA表达对于确定有效的治疗策略至关重要.
研究的目的:
- 检查乳腺癌组织中特定CTAs的表达模式.
- 评估CTA表达对患者结果的预后价值.
- 确定一个潜在的CTA面板,用于普遍乳腺癌免疫疗法.
主要方法:
- 免疫组织化学被用来评估MAGE-A4,MAGEA1,NY-ESO-1,KK-LC-1和PRAME表达在137个乳腺癌样本中,包括51个三阴性乳腺癌 (TNBC) 病例.
- 量化了PD-L1和瘤透淋巴细胞 (TIL) 的表达,并与CTA表达相关.
- 分析了临床数据的预后意义,并使用Kaplan-Meier绘图器进行验证.
主要成果:
- 与非TNBC相比,MAGE-A4,NY-ESO-1和KK-LC-1在TNBC中表达明显更高.
- 超过76%的TNBC病例表达了至少五个研究的CTA中的一个.
- 阳性表达MAGE-A4或PRAME与显著延长的无病生存 (DFS) 相关,由卡普兰-梅尔分析证实.
结论:
- MAGE-A4,NY-ESO-1,PRAME和KK-LC-1在乳腺癌中经常过度表达,特别是在TNBC中.
- 在乳腺癌患者中,MAGE-A4和PRAME表达可能作为长期DFS的预测生物标志物.
- 一个精心策划的CTA小组代表了一个有前途的战略,用于开发乳腺癌的普遍免疫治疗标.
更多相关视频
11:02Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
21.3K
13:19Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery
Published on: April 26, 2024
2.7K
相关概念视频
01:27Tumor Immunotherapy
556
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
556
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
01:30Cancer Vaccines
400
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
400